FOXO4-DRI's well-characterized mechanism and expanding research applications position it as an essential research tool for advancing our understanding of senescence biology and developing next-generation approaches to studying aging and age-related diseases in laboratory settings
Acute injury protocol: Weeks 12: 500mcg each peptide twice daily, localized + systemic Weeks 34: 500mcg each peptide once daily, systemic Weeks 56: 250mcg each peptide once daily, systemic Total duration: 6 weeks Chronic condition protocol: Weeks 14: 500mcg each peptide once daily Weeks 58: 250500mcg each peptide once daily (based on response) Weeks 912: 250mcg each peptide once daily or every other day Total duration: 12 weeks Post-surgical protocol: Days 17: 500mcg each peptide twice daily Weeks 24: 500mcg each peptide once daily Weeks 56: 250mcg each peptide once daily Total duration: 6 weeks Monitoring and Adjustments Protocols should track the following
Research Background This dual copper peptide blend combines GHK-Cu's well-documented effects on collagen synthesis and gene expression modulation with AHK-Cu's targeted effects on dermal papilla cells
Atlanta, GA: Centers for Disease Control and Prevention (US)
Its important to understand the difference between medically proven facts and research versus hype and TikTok trends
SeekPeptides members have access to detailed protocols, personalized guidance, and a community of experienced researchers who have navigated these exact steps